New Jersey Office Wants Physicians To Report Industry Financial Ties
This article was originally published in The Gray Sheet
New Jersey physicians should publicly report their financial ties with device and pharmaceutical firms as a condition of renewing their medical licenses, the state's Division of Consumer Affairs advised in a Dec. 4 report to New Jersey's Attorney General Anne Milgram
You may also be interested in...
House and Senate members continued to tinker with requirements for device firms to disclose payments to physicians in health care reform markup sessions last week
The attorney general of New Jersey is going after the device industry for failures to disclose possible financial conflicts of interest with clinical trial investigators, and wants FDA to strengthen its enforcement, as well
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.